The role of lipid mediators in hypoxic pulmonary vasoconstriction in newborns.
Bradley
L M
LM
Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4799.
Feuerstein
G
G
Goldstein
R E
RE
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000098:Acetophenones / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D019086:Bridged Bicyclo Compounds, Heterocyclic; D005231:Fatty Acids, Unsaturated; D006834:Hydrazines / Q000494:pharmacology; D000860:Hypoxia / Q000503:physiopathology*; D008055:Lipids / Q000502:physiology*; D010972:Platelet Activating Factor / Q000494:pharmacology; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D011652:Pulmonary Circulation / Q000187:drug effects; D013189:SRS-A / Q000037:antagonists & inhibitors / Q000494:pharmacology; D013552:Swine; D013777:Tetrazoles / Q000494:pharmacology; D013928:Thromboxane A2 / Q000037:antagonists & inhibitors; D014661:Vasoconstriction / Q000187:drug effects
D000098:Acetophenones; D019086:Bridged Bicyclo Compounds, Heterocyclic; D005231:Fatty Acids, Unsaturated; D006834:Hydrazines; D008055:Lipids; D010972:Platelet Activating Factor; D011450:Prostaglandin Endoperoxides, Synthetic; D013189:SRS-A; D013777:Tetrazoles; D013928:Thromboxane A2; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; C044660:LY 171883; C045749:SQ 29548